Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Application of Lenalidomide and Desamethasone in the Palliative Therapy of Patients With Multiple Myeloma

NCT00911105 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT00911105
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00911105 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Application of Lenalidomide and Desamethasone in the Palliative Therapy of Patients With Multiple Myeloma
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
May 31, 2009
Completion date
November 30, 2015
Enrollment
101 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma